- Overview:
- This study will explore the health benefits of once-weekly Tirzepatide with people who have a history of cardiovascular problems or risk factors; without diabetes.
- Staus:
- Enrolling
- Clinical Description:
- This study will investigate the effect of Tirzepatide on the reduction of morbidity and mortality in adults living with obesity/heart problems and provide any additional evidence of other improvements for this population. Tirzepatide has the potential of demonstrating clinically meaningful improvements in outcomes associated with weight loss.
- Target Age/Sex:
- 40+ years old, Male & Female with Obesity & Heart Problems
- Benefits:
- During this study, participants will receive cardiovascular disease related education/materials, medical condition education, weight-loss counseling, body trackers focusing on healthy lifestyles and improved outcomes.
- Study Length:
- TBD
- Link:
- ClinicalTrials.gov
